Skip to content

Research on Precise Regulation of Digestive System Health in Adults with Irritable Bowel Syndrome through Structured Diet

Research on Precise Regulation of Digestive System Health in Adults with Irritable Bowel Syndrome through Structured Diet

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400092555
Enrollment
Unknown
Registered
2024-11-19
Start date
2024-11-20
Completion date
Unknown
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Irritable Bowel Syndrome

Interventions

Control group:Restrict a similar amount of food as the other two groups, and the restriction difficulty is similar, but do not affect the intake of nutrients, fiber or fermentable oligosaccharides, di
Low FODMAP group:Limit intake of foods containing the following components: fructose, lactose, fructan and galactooligosaccharides, sugar alcohols.
Probiotics + Low FODMAP group:Based onthe limiting foods in the LFD group, foods rich in probiotics will be added

Sponsors

Peking University Third Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Meet the RomeIV diagnostic criteria for diarrheal IBS; 2. 18-60 years old; 3. IBS Symptom Severity Scale (IBS-SSS) score =175.

Exclusion criteria

Exclusion criteria: 1. Conditions that may affect the gut microbiota (e.g., inflammatory bowel disease, celiac disease, diabetes); 2. Patients with abdominal pain and diarrhea due to organic diseases; 3. Patients with abdominal surgery; 4. Patients with complications of heart, brain, liver, kidney and other systems; 5. Patients with organic diseases and biochemical abnormalities, such as abnormalities with hyroid function, blood routine, tumor markers, stool routines, abdominal B-scan ultrasonography, endoscopy, and other related examinations. 6. The duration of abdominal discomfort symptoms < 2 days; 7. Patients with serious mental problems or take related drugs; 8. Drug abusers or alcoholics; 9. Patients with special dietary habits (such as vegetarians); 10. People suffering from eating disorders; 11. Use of antibiotics, probiotics, and other drugs that may affect the study, and pre-colonoscopy bowel preparation within 4 weeks prior to the study; 12. Participants in other clinical trials; 13. Patients undergoing therapeutic dietary interventions; 14. Pregnant or lactating women; 15. Patients unable to communicate normally or unable to use communication equipment expertly; 16. Don't want to sign the informed consent.

Design outcomes

Primary

MeasureTime frame
Irritable Bowel Syndrome Symptom Severity Scale, IBS-SSS;

Secondary

MeasureTime frame
IBS-QOL;Bristol stool form scale;Hospital Anxiety and Depression Scale, HADS;Patient Health Questionnaire, PHQ-12;hydrogen breath test;Metabolomics indicators;gut microbiota;

Countries

China

Contacts

Public ContactLiu Wei

Peking University Third Hospital

liuwei19560912@163.com+86 188 1133 1956

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026